Multicenter prospective study of stereotactic body radiotherapy for untreated solitary primary hepatocellular carcinoma - Multicenter study of SBRT for untreated solitary HCC (STRSPH study)

STRSPH study group0 个研究点目标入组 36 人开始时间: 2014年1月30日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Ascites uncontrollable with medication 2)History of radiation therapy to the lesion of interest 3)Having esophageal varices which are at great risk of bleeding 4)Having active infectious diseases 5)Associated with other malignancies (simultaneous double cancer and heterochronic double cancer with disease-free time within 5 years), excluding carcinoma-in-situ or submucosal carcinoma treated with curative local therapies, glottis cancer staged as T1N0M0, low-risk prostate cancer (T1-2a, Gleason score 2-6 and PSA < 10 ng/ml), Stage I breast cancer, and other malignancies with comparatively favorable prognosis 6)Having interstitial pneumonitis, pulmonary fibrosis or severe respiratory disease such as pulmonary emphysema 7)Associated with mental illness or manifestation complicating study participation 8)Being pregnant or possible conception 9) Miscellaneous inappropriate conditions judged by physicians

发起方

STRSPH study group